Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Subscriptions

Table of Contents

01 February 2022; volume 59, issue 2

Editorials

  • You have accessRestricted access
    Management of recurrent transudative pleural effusions: can we REDUCE unnecessary interventions?
    Christopher R. Gilbert, José M. Porcel
    European Respiratory Journal 59 (2) 2101942; DOI: 10.1183/13993003.01942-2021 Published 24 February 2022
  • Open Access
    Convalescent plasma for SARS-CoV-2 infection: win or learn
    Enric Contreras-Barbeta, Anna Millan, Jordi Rello
    European Respiratory Journal 59 (2) 2102076; DOI: 10.1183/13993003.02076-2021 Published 10 February 2022
  • Open Access
    Prone positioning for non-intubated hypoxaemic patients with COVID-19: cheap, easy and makes sense, but does it work?
    Eric D. Morrell, Mark M. Wurfel
    European Respiratory Journal 59 (2) 2102416; DOI: 10.1183/13993003.02416-2021 Published 24 February 2022
  • Open Access
    Long COVID: to investigate immunological mechanisms and sex/gender related aspects as fundamental steps for tailored therapy
    Elena Ortona, Walter Malorni
    European Respiratory Journal 59 (2) 2102245; DOI: 10.1183/13993003.02245-2021 Published 3 February 2022
  • You have accessRestricted access
    The quest for biomarkers in asthma: challenging the T2 versus non-T2 paradigm
    Sven F. Seys, Merete B. Long
    European Respiratory Journal 59 (2) 2102669; DOI: 10.1183/13993003.02669-2021 Published 17 February 2022
  • You have accessRestricted access
    In vitro assessment of triple combination therapy for the most common disease-associated mutation in cystic fibrosis
    Han-I Yeh, Tzyh-Chang Hwang
    European Respiratory Journal 59 (2) 2102380; DOI: 10.1183/13993003.02380-2021 Published 24 February 2022
  • Open Access
    Does acute and persistent metabolic dysregulation in COVID-19 point to novel biomarkers and future therapeutic strategies?
    Emily M. Hartsell, Mark N. Gillespie, Raymond J. Langley
    European Respiratory Journal 59 (2) 2102417; DOI: 10.1183/13993003.02417-2021 Published 24 February 2022
  • Open Access
    ECMO during the COVID-19 pandemic: moving from rescue therapy to more reasonable indications
    Christian Karagiannidis, Thomas Bein, Tobias Welte
    European Respiratory Journal 59 (2) 2103262; DOI: 10.1183/13993003.03262-2021 Published 10 February 2022

Original Research Articles

  • Pleural disease

    • You have accessRestricted access
      Randomised trial of indwelling pleural catheters for refractory transudative pleural effusions
      Steven P. Walker, Oliver Bintcliffe, Emma Keenan, Louise Stadon, Matthew Evison, Mohammed Haris, Thapas Nagarajan, Alex West, Alina Ionescu, Benjamin Prudon, Anur Guhan, Rehan Mustafa, Jurgen Herre, David Arnold, Rahul Bhatnagar, Brennan Kahan, Robert F. Miller, Najib M. Rahman, Nick A. Maskell
      European Respiratory Journal 59 (2) 2101362; DOI: 10.1183/13993003.01362-2021 Published 24 February 2022
  • Infection

    • Open Access
      Convalescent plasma for COVID-19 in hospitalised patients: an open-label, randomised clinical trial
      Leo Sekine, Beatriz Arns, Bruna R. Fabro, Murillo M. Cipolatt, Rafael R.G. Machado, Edison L. Durigon, Edino Parolo, José Augusto S. Pellegrini, Marina V. Viana, Patrícia Schwarz, Thiago C. Lisboa, José Miguel S. Dora, Julia P. Portich, Alessandra A. Paz, Lucia Silla, Almeri M. Balsan, Felipe da-Silva Schirmer, Juliana P.M. Franz, Luciana M. da-Silveira, Raquel C. Breunig, Viviana Petersen, Monalisa Sosnoski, Nanci F. Mesquita, Fabiana Caroline Z. Volpato, Daniel Sganzerla, Maicon Falavigna, Regis G. Rosa, Alexandre P. Zavascki on behalf of PLACOVID Study Group
      European Respiratory Journal 59 (2) 2101471; DOI: 10.1183/13993003.01471-2021 Published 10 February 2022
    • Open Access
      Early high antibody titre convalescent plasma for hospitalised COVID-19 patients: DAWn-plasma
      Timothy Devos, Quentin Van Thillo, Veerle Compernolle, Tomé Najdovski, Marta Romano, Nicolas Dauby, Laurent Jadot, Mathias Leys, Evelyne Maillart, Sarah Loof, Lucie Seyler, Martial Moonen, Michel Moutschen, Niels Van Regenmortel, Kevin K. Ariën, Cyril Barbezange, Albrecht Betrains, Mutien Garigliany, Matthias M. Engelen, Iwein Gyselinck, Piet Maes, Alexander Schauwvlieghe, Laurens Liesenborghs, Ann Belmans, Peter Verhamme, Geert Meyfroidt for the DAWn-plasma investigators
      European Respiratory Journal 59 (2) 2101724; DOI: 10.1183/13993003.01724-2021 Published 10 February 2022
    • Open Access
      Prognostic factors for adverse outcomes in patients with COVID-19: a field-wide systematic review and meta-analysis
      Vanesa Bellou, Ioanna Tzoulaki, Maarten van Smeden, Karel G.M. Moons, Evangelos Evangelou, Lazaros Belbasis
      European Respiratory Journal 59 (2) 2002964; DOI: 10.1183/13993003.02964-2020 Published 3 February 2022
  • Infection and critical care

    • Open Access
      Awake prone positioning and oxygen therapy in patients with COVID-19: the APRONOX study
      Orlando R. Perez-Nieto, Diego Escarraman-Martinez, Manuel A. Guerrero-Gutierrez, Eder I. Zamarron-Lopez, Javier Mancilla-Galindo, Ashuin Kammar-García, Miguel A. Martinez-Camacho, Ernesto Deloya-Tomás, Jesús S. Sanchez-Díaz, Luis A. Macías-García, Raúl Soriano-Orozco, Gabriel Cruz-Sánchez, José D. Salmeron-Gonzalez, Marco A. Toledo-Rivera, Ivette Mata-Maqueda, Luis A. Morgado-Villaseñor, Jenner J. Martinez-Mazariegos, Raymundo Flores Ramirez, Josue L. Medina-Estrada, Silvio A. Ñamendys-Silva on behalf of the APRONOX Group
      European Respiratory Journal 59 (2) 2100265; DOI: 10.1183/13993003.00265-2021 Published 24 February 2022
  • Infection and paediatrics

    • Open Access
      Risk factors for post-COVID-19 condition in previously hospitalised children using the ISARIC Global follow-up protocol: a prospective cohort study
      Ismail M. Osmanov, Ekaterina Spiridonova, Polina Bobkova, Aysylu Gamirova, Anastasia Shikhaleva, Margarita Andreeva, Oleg Blyuss, Yasmin El-Taravi, Audrey DunnGalvin, Pasquale Comberiati, Diego G. Peroni, Christian Apfelbacher, Jon Genuneit, Lyudmila Mazankova, Alexandra Miroshina, Evgeniya Chistyakova, Elmira Samitova, Svetlana Borzakova, Elena Bondarenko, Anatoliy A. Korsunskiy, Irina Konova, Sarah Wulf Hanson, Gail Carson, Louise Sigfrid, Janet T. Scott, Matthew Greenhawt, Elizabeth A. Whittaker, Elena Garralda, Olivia V. Swann, Danilo Buonsenso, Dasha E. Nicholls, Frances Simpson, Christina Jones, Malcolm G. Semple, John O. Warner, Theo Vos, Piero Olliaro, Daniel Munblit and the Sechenov StopCOVID Research Team
      European Respiratory Journal 59 (2) 2101341; DOI: 10.1183/13993003.01341-2021 Published 3 February 2022
  • Paediatrics

    • You have accessRestricted access
      Predicting the risk of respiratory distress in newborns with congenital pulmonary malformations
      Christophe Delacourt, Nathalie Bertille, Laurent J. Salomon, Makan Rahshenas, Alexandra Benachi, Arnaud Bonnard, Laure Choupeaux, Virginie Fouquet, Valérie Goua, Frédéric Hameury, Erik Hervieux, Jean-Marie Jouannic, Naziha Khen-Dunlop, Gwenaelle Le Bouar, Jérôme Massardier, Léa Roditis, Jonathan Rosenblatt, Agnès Sartor, Catherine Thong-Vanh, Nathalie Lelong, Babak Khoshnood , for the MALFPULM study group
      European Respiratory Journal 59 (2) 2100949; DOI: 10.1183/13993003.00949-2021 Published 3 February 2022
  • Asthma

    • Open Access
      Plasma proteins elevated in severe asthma despite oral steroid use and unrelated to Type-2 inflammation
      Maria Sparreman Mikus, Johan Kolmert, Lars I. Andersson, Jörgen Östling, Richard G. Knowles, Cristina Gómez, Magnus Ericsson, John-Olof Thörngren, Payam Emami Khoonsari, Barbro Dahlén, Maciej Kupczyk, Bertrand De Meulder, Charles Auffray, Per S. Bakke, Bianca Beghe, Elisabeth H. Bel, Massimo Caruso, Pascal Chanez, Bo Chawes, Stephen J. Fowler, Mina Gaga, Thomas Geiser, Mark Gjomarkaj, Ildikó Horváth, Peter H. Howarth, Sebastian L. Johnston, Guy Joos, Norbert Krug, Paolo Montuschi, Jacek Musial, Ewa Niżankowska-Mogilnicka, Henric K. Olsson, Alberto Papi, Klaus F. Rabe, Thomas Sandström, Dominick E. Shaw, Nikolaos M. Siafakas, Mathias Uhlén, John H. Riley, Stewart Bates, Roelinde J.M. Middelveld, Craig E. Wheelock, Kian Fan Chung, Ian M. Adcock, Peter J. Sterk, Ratko Djukanovic, Peter Nilsson, Sven-Erik Dahlén, Anna James on behalf of the U-BIOPRED (Unbiased Biomarkers for the Prediction of Respiratory Disease outcome) Study Group and the BIOAIR (Longitudinal Assessment of Clinical Course and Biomarkers in Severe Chronic Airway Disease) Consortium
      European Respiratory Journal 59 (2) 2100142; DOI: 10.1183/13993003.00142-2021 Published 17 February 2022
  • Asthma and paediatrics

    • You have accessRestricted access
      Prenatal tobacco exposure and risk of asthma and allergy outcomes in childhood
      Rikke Bjersand Sunde, Jonathan Thorsen, Casper-Emil Tingskov Pedersen, Jakob Stokholm, Klaus Bønnelykke, Bo Chawes, Hans Bisgaard
      European Respiratory Journal 59 (2) 2100453; DOI: 10.1183/13993003.00453-2021 Published 17 February 2022
  • Pulmonary vascular disease

    • You have accessRestricted access
      Randomised controlled trial of a prognostic assessment and management pathway to reduce the length of hospital stay in normotensive patients with acute pulmonary embolism
      David Jiménez, Carmen Rodríguez, Francisco León, Luis Jara-Palomares, Raquel López-Reyes, Pedro Ruiz-Artacho, Teresa Elías, Remedios Otero, Alberto García-Ortega, Agustina Rivas-Guerrero, Jaime Abelaira, Sonia Jiménez, Alfonso Muriel, Raquel Morillo, Deisy Barrios, Raphael Le Mao, Roger D. Yusen, Behnood Bikdeli, Manuel Monreal, José Luis Lobo for the IPEP investigators
      European Respiratory Journal 59 (2) 2100412; DOI: 10.1183/13993003.00412-2021 Published 10 February 2022
  • Interstitial lung disease

    • Open Access
      Effects of nintedanib by inclusion criteria for progression of interstitial lung disease
      Toby M. Maher, Kevin K. Brown, Michael Kreuter, Anand Devaraj, Simon L.F. Walsh, Lisa H. Lancaster, Elizabeth A. Belloli, Maria Padilla, Juergen Behr, Rainer-Georg Goeldner, Kay Tetzlaff, Rozsa Schlenker-Herceg, Kevin R. Flaherty on behalf of the INBUILD trial investigators
      European Respiratory Journal 59 (2) 2004587; DOI: 10.1183/13993003.04587-2020 Published 3 February 2022
  • Interstitial lung disease and genetics

    • Open Access
      Genetically increased circulating FUT3 level leads to reduced risk of idiopathic pulmonary fibrosis: a Mendelian randomisation study
      Tomoko Nakanishi, Agustin Cerani, Vincenzo Forgetta, Sirui Zhou, Richard J. Allen, Olivia C. Leavy, Masaru Koido, Deborah Assayag, R. Gisli Jenkins, Louise V. Wain, Ivana V. Yang, G. Mark Lathrop, Paul J. Wolters, David A. Schwartz, J. Brent Richards
      European Respiratory Journal 59 (2) 2003979; DOI: 10.1183/13993003.03979-2020 Published 10 February 2022
  • Cystic fibrosis

    • You have accessRestricted access
      The rescue of F508del-CFTR by elexacaftor/tezacaftor/ivacaftor (Trikafta) in human airway epithelial cells is underestimated due to the presence of ivacaftor
      Frédéric Becq, Sandra Mirval, Thomas Carrez, Manuella Lévêque, Arnaud Billet, Christelle Coraux, Edouard Sage, Anne Cantereau
      European Respiratory Journal 59 (2) 2100671; DOI: 10.1183/13993003.00671-2021 Published 24 February 2022
    • Open Access
      Efficacy and safety of inhaled ENaC inhibitor BI 1265162 in patients with cystic fibrosis: BALANCE-CF 1, a randomised, phase II study
      Christopher H. Goss, Isabelle Fajac, Raksha Jain, Wolfgang Seibold, Abhya Gupta, Ming-Chi Hsu, Sivagurunathan Sutharsan, Jane C. Davies, Marcus A. Mall
      European Respiratory Journal 59 (2) 2100746; DOI: 10.1183/13993003.00746-2021 Published 17 February 2022
  • COPD and genetics

    • You have accessRestricted access
      Associations of genetic risk and smoking with incident COPD
      Pei-Dong Zhang, Xi-Ru Zhang, Ao Zhang, Zhi-Hao Li, Dan Liu, Yu-Jie Zhang, Chen Mao
      European Respiratory Journal 59 (2) 2101320; DOI: 10.1183/13993003.01320-2021 Published 10 February 2022
  • Lung transplant

    • You have accessRestricted access
      Multi-omics profiling predicts allograft function after lung transplantation
      Martin L. Watzenboeck, Anna-Dorothea Gorki, Federica Quattrone, Riem Gawish, Stefan Schwarz, Christopher Lambers, Peter Jaksch, Karin Lakovits, Sophie Zahalka, Nina Rahimi, Philipp Starkl, Dörte Symmank, Tyler Artner, Céline Pattaroni, Nikolaus Fortelny, Kristaps Klavins, Florian Frommlet, Benjamin J. Marsland, Konrad Hoetzenecker, Stefanie Widder, Sylvia Knapp
      European Respiratory Journal 59 (2) 2003292; DOI: 10.1183/13993003.03292-2020 Published 3 February 2022
  • Sleep

    • You have accessRestricted access
      Physical activity, sedentary behaviour and incidence of obstructive sleep apnoea in three prospective US cohorts
      Yue Liu, Lin Yang, Meir J. Stampfer, Susan Redline, Shelley S. Tworoger, Tianyi Huang
      European Respiratory Journal 59 (2) 2100606; DOI: 10.1183/13993003.00606-2021 Published 3 February 2022
  • Infection and basic science

    • Open Access
      Metabolomic analyses reveal new stage-specific features of COVID-19
      Hongling Jia, Chaowu Liu, Dantong Li, Qingsheng Huang, Dong Liu, Ying Zhang, Chang Ye, Di Zhou, Yang Wang, Yanlian Tan, Kuibiao Li, Fangqin Lin, Haiqing Zhang, Jingchao Lin, Yang Xu, Jingwen Liu, Qing Zeng, Jian Hong, Guobing Chen, Hao Zhang, Lingling Zheng, Xilong Deng, Changwen Ke, Yunfei Gao, Jun Fan, Biao Di, Huiying Liang
      European Respiratory Journal 59 (2) 2100284; DOI: 10.1183/13993003.00284-2021 Published 24 February 2022
  • Paediatrics and basic science

    • Open Access
      Macrophage-derived IL-6 trans-signalling as a novel target in the pathogenesis of bronchopulmonary dysplasia
      Dharmesh Hirani, Cristina M. Alvira, Soula Danopoulos, Carlos Milla, Michele Donato, Lu Tian, Jasmine Mohr, Katharina Dinger, Christina Vohlen, Jaco Selle, Silke v. Koningsbruggen-Rietschel, Verena Barbarino, Christian Pallasch, Stefan Rose-John, Margarete Odenthal, Gloria S. Pryhuber, Siavash Mansouri, Rajkumar Savai, Werner Seeger, Purvesh Khatri, Denise Al Alam, Jörg Dötsch, Miguel A. Alejandre Alcazar
      European Respiratory Journal 59 (2) 2002248; DOI: 10.1183/13993003.02248-2020 Published 17 February 2022
  • Cystic fibrosis and basic science

    • You have accessRestricted access
      Treatment of cystic fibrosis airway cells with CFTR modulators reverses aberrant mucus properties via hydration
      Cameron B. Morrison, Kendall M. Shaffer, Kenza C. Araba, Matthew R. Markovetz, Jason A. Wykoff, Nancy L. Quinney, Shuyu Hao, Martial F. Delion, Alexis L. Flen, Lisa C. Morton, Jimmy Liao, David B. Hill, Mitchell L. Drumm, Wanda K. O'Neal, Mehmet Kesimer, Martina Gentzsch, Camille Ehre
      European Respiratory Journal 59 (2) 2100185; DOI: 10.1183/13993003.00185-2021 Published 3 February 2022

State of the Art

  • You have accessRestricted access
    Alpha-1 antitrypsin deficiency: clarifying the role of the putative protective threshold
    Alessandro N. Franciosi, Daniel Fraughen, Tomás P. Carroll, Noel G. McElvaney
    European Respiratory Journal 59 (2) 2101410; DOI: 10.1183/13993003.01410-2021 Published 10 February 2022

Agora

  • Research letters

    • You have accessRestricted access
      Restrictive spirometry pattern and abnormal cardiopulmonary response to exercise in transthyretin cardiac amyloidosis
      Rishika Banydeen, Giuseppe Vergaro, Antoine Deney, Astrid Monfort, Michele Emdin, Olivier Lairez, Anna Gaelle Giguet, Jocelyn Inamo, Remi Neviere
      European Respiratory Journal 59 (2) 2102838; DOI: 10.1183/13993003.02838-2021 Published 24 February 2022
    • Open Access
      High-dose versus low-dose prednisolone in symptomatic patients with post-COVID-19 diffuse parenchymal lung abnormalities: an open-label, randomised trial (the COLDSTER trial)
      Sahajal Dhooria, Shivani Chaudhary, Inderpaul Singh Sehgal, Ritesh Agarwal, Siddhant Arora, Mandeep Garg, Nidhi Prabhakar, Goverdhan Dutt Puri, Ashish Bhalla, Vikas Suri, Lakshmi Narayana Yaddanapudi, Valliappan Muthu, Kuruswamy Thurai Prasad, Ashutosh Nath Aggarwal
      European Respiratory Journal 59 (2) 2102930; DOI: 10.1183/13993003.02930-2021 Published 17 February 2022
    • Open Access
      Risk factors for mortality in patients with COVID-19 needing extracorporeal respiratory support
      Jordi Riera, Sara Alcántara, Camilo Bonilla, Phillip Fortuna, Aaron Blandino Ortiz, Ana Vaz, Carlos Albacete, Pablo Millán, Pilar Ricart, María Victoria Boado, Pablo Ruiz de Gopegui, Patricia Santa Teresa, Elena Sandoval, Helena Pérez-Chomón, Alfredo González-Pérez, Jorge Duerto, Ricardo Gimeno, Joaquín Colomina, Vanesa Gómez, Gloria Renedo, José Naranjo, Manuel Alfonso García, Emilio Rodríguez-Ruiz, Pedro Eduardo Silva, Daniel Pérez, Javier Veganzones, Roberto Voces, Sergi Martínez, Pablo Blanco-Schweizer, Marta García, Héctor Villanueva-Fernández, María Paz Fuset, Stephani María Luna, María Martínez-Martínez, Eduard Argudo, Luis Chiscano, Roberto Roncon-Albuquerque Jr
      European Respiratory Journal 59 (2) 2102463; DOI: 10.1183/13993003.02463-2021 Published 10 February 2022
    • Open Access
      Higher frequency of comorbidities in fully vaccinated patients admitted to the ICU due to severe COVID-19: a prospective, multicentre, observational study
      Anna Motos, Alexandre López-Gavín, Jordi Riera, Adrián Ceccato, Laia Fernández-Barat, Jesús F. Bermejo-Martin, Ricard Ferrer, David de Gonzalo-Calvo, Rosario Menéndez, Raquel Pérez-Arnal, Dario García-Gasulla, Alejandro Rodriguez, Oscar Peñuelas, José Ángel Lorente, Raquel Almansa, Albert Gabarrus, Judith Marin-Corral, Pilar Ricart, Ferran Roche-Campo, Susana Sancho Chinesta, Lorenzo Socias, Ferran Barbé, Antoni Torres on behalf of the CIBERESUCICOVID Project (COV20/00110, ISCIII)
      European Respiratory Journal 59 (2) 2102275; DOI: 10.1183/13993003.02275-2021 Published 10 February 2022
    • You have accessRestricted access
      Evaluation of the PADIS score stratifying risk for venous thromboembolism recurrence after a first unprovoked pulmonary embolism: results from the REVERSE study
      Lucia Caiano, Rhys Sharkey, Marc A. Rodger, Michael J. Kovacs, Grégoire Le Gal, Aurélien Delluc
      European Respiratory Journal 59 (2) 2101801; DOI: 10.1183/13993003.01801-2021 Published 3 February 2022
    • Open Access
      A longitudinal analysis of pneumococcal vaccine serotypes in pneumonia patients in Germany
      Christina Bahrs, Miriam Kesselmeier, Martin Kolditz, Santiago Ewig, Gernot Rohde, Grit Barten-Neiner, Jan Rupp, Martin Witzenrath, Tobias Welte, Mathias W. Pletz for the CAPNETZ Study Group
      European Respiratory Journal 59 (2) 2102432; DOI: 10.1183/13993003.02432-2021 Published 3 February 2022
  • Correspondence

    • Open Access
      ORF8/ORF8a: a difference between SARS-CoV-2 and SARS-CoV
      Milad Zandi
      European Respiratory Journal 59 (2) 2102818; DOI: 10.1183/13993003.02818-2021 Published 24 February 2022
    • Open Access
      High-sensitive cardiac troponin after CPAP in obstructive sleep apnoea: the adjusted analytical change limit (adjACL) for small variations at low concentrations
      Denis Monneret
      European Respiratory Journal 59 (2) 2103022; DOI: 10.1183/13993003.03022-2021 Published 17 February 2022
    • You have accessRestricted access
      Reply: High-sensitive cardiac troponin after CPAP in obstructive sleep apnoea
      Mary Sau-Man Ip, Hung-Fat Tse, David Chi-Leung Lam, Macy Mei-Sze Lui
      European Respiratory Journal 59 (2) 2103176; DOI: 10.1183/13993003.03176-2021 Published 17 February 2022
    • You have accessRestricted access
      Comparison of the treatment guidelines for sarcoidosis: common sense in the search for evidence
      Vivienne Kahlmann, Catharina C. Moor, Jelle R. Miedema, Marlies S. Wijsenbeek
      European Respiratory Journal 59 (2) 2103114; DOI: 10.1183/13993003.03114-2021 Published 10 February 2022
    • Open Access
      Remote patient monitoring in COVID-19: a critical appraisal
      Henri Gruwez, Emma Bakelants, Pauline Dreesen, Jolien Broekmans, Maarten Criel, Michiel Thomeer, Pieter Vandervoort, David Ruttens
      European Respiratory Journal 59 (2) 2102697; DOI: 10.1183/13993003.02697-2021 Published 3 February 2022
Back to top
PreviousNext
European Respiratory Journal: 59 (2)
  • Table of Contents
  • Index by author

Search Within This Issue

Jump to

  • Editorials
  • Original Research Articles
    • Pleural disease
    • Infection
    • Infection and critical care
    • Infection and paediatrics
    • Paediatrics
    • Asthma
    • Asthma and paediatrics
    • Pulmonary vascular disease
    • Interstitial lung disease
    • Interstitial lung disease and genetics
    • Cystic fibrosis
    • COPD and genetics
    • Lung transplant
    • Sleep
    • Infection and basic science
    • Paediatrics and basic science
    • Cystic fibrosis and basic science
  • State of the Art
  • Agora
    • Research letters
    • Correspondence
Manage Table of content Alerts
  • Most Read
  • Twitter
Loading
  • Pulsus paradoxus
  • ERS/ATS technical standard on interpretive strategies for routine lung function tests
  • European Respiratory Society guidelines for the diagnosis of asthma in adults
  • ERS clinical practice guidelines on treatment of sarcoidosis
  • The association between SARS-CoV-2 RT-PCR cycle threshold and mortality in a community cohort
More...

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society